Erythropoietin Drugs Market (By Drug Class: Biologics, Biosimilars; By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others; By Application: Cancer, Hematology, Renal diseases, Neurology) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. Industry Overview of Erythropoietin Drugs

1.1. Definition and Scope 

1.1.1. Definition of Erythropoietin Drugs

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Erythropoietin Drugs Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Erythropoietin Drugs Market By Drug Class

1.2.3. Erythropoietin Drugs Market By Product

1.2.4. Erythropoietin Drugs Market By Application

1.2.5. Erythropoietin Drugs Market by Regions

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restrain 1

3.2.2. Restrain 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Erythropoietin Drugs Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Erythropoietin Drugs Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2019

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019

4.2. R&D Status and Application Source of Erythropoietin Drugs Major Manufacturers in 2019

CHAPTER 5. Erythropoietin Drugs Market By Drug Class

5.1. Introduction

5.2. Erythropoietin Drugs Revenue By Drug Class

5.2.1. Erythropoietin Drugs Revenue (US$ Mn) and Forecast, By Drug Class, 2016-2027

5.2.2. Biologics

5.2.2.1. Biologics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

5.2.3. Biosimilars

5.2.3.1. Biosimilars Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Erythropoietin Drugs Market Revenue By Product

6.1. Introduction

6.2. Erythropoietin Drugs Revenue (US$ Mn) By Product

6.2.1. Erythropoietin Drugs Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

6.2.2. Epoetin-alfa

6.2.2.1. Epoetin-alfa Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.3. Epoetin-beta

6.2.3.1. Epoetin-beta Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.4. Darbepoetin-alfa

6.2.4.1. Darbepoetin-alfa Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.5. Others

6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. Erythropoietin Drugs Market By Application 

7.1. Introduction

7.2. Erythropoietin Drugs Revenue (US$ Mn) By Application

7.2.1. Erythropoietin Drugs Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

7.2.2. Cancer

7.2.2.1. Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

7.2.3. Hematology

7.2.3.1. Hematology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

7.2.4. Renal diseases

7.2.4.1. Renal diseases Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

7.2.5. Neurology

7.2.5.1. Neurology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 8. North America Erythropoietin Drugs Market By Country 

8.1. North America Erythropoietin Drugs Overview

8.2. U.S.

8.2.1. U.S. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027

8.2.2. U.S. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027

8.2.3. U.S. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

8.3. Canada

8.3.1. Canada Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027

8.3.2. Canada Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027

8.3.3. Canada Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

8.4. North America PEST Analysis

CHAPTER 9. Europe Erythropoietin Drugs Market By Country

9.1. Europe Erythropoietin Drugs Market Overview

9.2. U.K.

9.2.1. U.K. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027

9.2.2. U.K. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027

9.2.3. U.K. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

9.3. Germany

9.3.1. Germany Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027

9.3.2. Germany Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027

9.3.3. Germany Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

9.4. France 

9.4.1. France Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027

9.4.2. France Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027

9.4.3. France Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

9.5. Spain

9.5.1. Spain Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027

9.5.2. Spain Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027

9.5.3. Spain Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

9.6. Rest of Europe

9.6.1. Rest of Europe Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027

9.6.2. Rest of Europe Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027

9.6.3. Rest of Europe Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Erythropoietin Drugs Market By Country

10.1. Asia Pacific Erythropoietin Drugs Market Overview

10.2. China

10.2.1. China Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

10.2.2. China Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

10.2.3. China Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.3. Japan

10.3.1. Japan Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

10.3.2. Japan Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

10.3.3. Japan Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.4. India

10.4.1. India Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

10.4.2. India Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

10.4.3. India Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.5. Australia

10.5.1. Australia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

10.5.2. Australia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

10.5.3. Australia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.6. South Korea

10.6.1. South Korea Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

10.6.2. South Korea Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

10.6.3. South Korea Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

10.7.2. Rest of Asia-Pacific Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

10.7.3. Rest of Asia-Pacific Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Erythropoietin Drugs Market By Country

11.1. Latin America Erythropoietin Drugs Market Overview

11.2. Brazil

11.2.1. Brazil Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

11.2.2. Brazil Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

11.2.3. Brazil Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

11.3. Mexico

11.3.1. Mexico Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

11.3.2. Mexico Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

11.3.3. Mexico Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

11.4. Rest of Latin America

11.4.1. Rest of Latin America Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

11.4.2. Rest of Latin America Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027

11.4.3. Rest of Latin America Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Erythropoietin Drugs Market By Country 

12.1. Middle East & Africa Erythropoietin Drugs Market Overview

12.2. Saudi Arabia

12.2.1. Saudi Arabia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

12.2.2. Saudi Arabia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

12.2.3. Saudi Arabia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

12.3. UAE

12.3.1. UAE Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

12.3.2. UAE Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

12.3.3. UAE Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027

12.4.2. Rest of Middle East & Africa Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

12.4.3. Rest of Middle East & Africa Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Erythropoietin Drugs

13.1. Erythropoietin Drugs Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Erythropoietin Drugs Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. COMPANY PROFILE

14.1. Johnson & Johnson

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (US$ Mn), 2019

14.1.3.2. Johnson & Johnson 2019 Erythropoietin Drugs Business Regional Distribution

14.1.4. Product/ Service and Specification

14.1.5. Recent Developments & Business Strategy

14.1.6. Manufacturing Plant Footprint Analysis

14.2. Celltrion

14.3. Teva Pharmaceutical Industries Ltd.

14.4. Amgen, Inc.

14.5. F. Hoffmann-La Roche Ltd

14.6. LG Life Sciences Ltd. 

14.7. Biocon Limited

14.8. Others

Cart Summary